ZA927955B - Cyclohexaneacetic acid derivatives. - Google Patents

Cyclohexaneacetic acid derivatives.

Info

Publication number
ZA927955B
ZA927955B ZA927955A ZA927955A ZA927955B ZA 927955 B ZA927955 B ZA 927955B ZA 927955 A ZA927955 A ZA 927955A ZA 927955 A ZA927955 A ZA 927955A ZA 927955 B ZA927955 B ZA 927955B
Authority
ZA
South Africa
Prior art keywords
acid derivatives
cyclohexaneacetic acid
cyclohexaneacetic
derivatives
acid
Prior art date
Application number
ZA927955A
Other languages
English (en)
Inventor
Barry Porter
Colin David Eldred
Henry Anderson Kelly
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ZA927955B publication Critical patent/ZA927955B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA927955A 1991-10-16 1992-10-15 Cyclohexaneacetic acid derivatives. ZA927955B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919122016A GB9122016D0 (en) 1991-10-16 1991-10-16 Chemical compounds

Publications (1)

Publication Number Publication Date
ZA927955B true ZA927955B (en) 1993-08-13

Family

ID=10703062

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA927955A ZA927955B (en) 1991-10-16 1992-10-15 Cyclohexaneacetic acid derivatives.

Country Status (10)

Country Link
EP (2) EP0609282A1 (zh)
JP (1) JPH07500327A (zh)
CN (1) CN1073433A (zh)
AU (1) AU2689292A (zh)
GB (1) GB9122016D0 (zh)
IL (1) IL103437A0 (zh)
MX (1) MX9205916A (zh)
TW (1) TW217409B (zh)
WO (1) WO1993008181A1 (zh)
ZA (1) ZA927955B (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0612313A1 (en) * 1991-11-14 1994-08-31 Glaxo Group Limited Piperidine acetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
WO1993014077A1 (en) * 1992-01-21 1993-07-22 Glaxo Group Limited Piperidineacetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
DE4234295A1 (de) * 1992-10-12 1994-04-14 Thomae Gmbh Dr K Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE69411900T2 (de) * 1993-03-29 1998-12-10 Zeneca Ltd., London Heterozyklische derivate als plätchenaggregationsinhibitoren
US5750754A (en) * 1993-03-29 1998-05-12 Zeneca Limited Heterocyclic compounds
ZW4194A1 (en) * 1993-03-29 1994-12-21 Zeneca Ltd Heterocyclic compounds
US5753659A (en) * 1993-03-29 1998-05-19 Zeneca Limited Heterocyclic compouds
US5652242A (en) * 1993-03-29 1997-07-29 Zeneca Limited Heterocyclic derivatives
GB9313268D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Chemical compounds
GB9313285D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Acid derivatives
US5463011A (en) * 1993-06-28 1995-10-31 Zeneca Limited Acid derivatives
USRE39263E1 (en) * 1994-05-04 2006-09-05 Bayer Aktiengesellschaft Substituted aromatic thiocarboxylic acid amides and their use as herbicides
CN1113875C (zh) 1994-05-04 2003-07-09 拜尔公司 取代的芳族硫代羧酰胺及其作为除草剂的用途
WO1997002245A1 (fr) * 1995-07-06 1997-01-23 Japan Tobacco Inc. Derives de benzamidoxime et leur utilisation a des fins medicinales
DE19524765A1 (de) * 1995-07-07 1997-01-09 Boehringer Mannheim Gmbh Neue Oxazolidinonderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0897920A4 (en) * 1996-03-29 1999-06-30 Meiji Seika Co NOVEL HETEROCYCLIC COMPOUNDS HAVING AN INHIBITION EFFECT OF PLATELET AGGREGATION
CZ305198A3 (cs) * 1996-03-30 1999-02-17 Roche Diagnostics Gmbh Nové deriváty oxazolidinu, způsob jejich výroby a léčiva je obsahující
EP1054871A2 (en) 1998-04-01 2000-11-29 Du Pont Pharmaceuticals Company Pyrimidines and triazines as integrin antagonists
SE9901573D0 (sv) 1999-05-03 1999-05-03 Astra Ab New compounds
GB9912417D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH565761A5 (en) * 1969-06-05 1975-08-29 Ciba Geigy Ag Alpha-phenyl carboxylic acids
DE3139970A1 (de) * 1981-10-08 1983-04-28 Boehringer Mannheim Gmbh, 6800 Mannheim Neue carbonsaeurederivate, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
WO1993008181A1 (en) 1993-04-29
EP0609282A1 (en) 1994-08-10
IL103437A0 (en) 1993-03-15
AU2689292A (en) 1993-05-21
EP0537980A1 (en) 1993-04-21
GB9122016D0 (en) 1991-11-27
JPH07500327A (ja) 1995-01-12
MX9205916A (es) 1993-06-01
CN1073433A (zh) 1993-06-23
TW217409B (zh) 1993-12-11

Similar Documents

Publication Publication Date Title
EP0641203A4 (en) AMIDAZOLYL-ALCENOIC ACIDS.
EP0520277A3 (en) 7-azaisoindolinyl-quinolone- and naphthyridoncarboxylic acid derivatives
ZA927955B (en) Cyclohexaneacetic acid derivatives.
PH30227A (en) 7-Isoindolinyl-quinolone-carboxylic acid derivatives
HU9400143D0 (en) Quinolon-and naphtiridon-carboxylic acid derivatives
EP0645391A3 (en) Aminobenzoic acid derivatives.
IL103538A0 (en) Quinoxaline-carboxylic and-phosphonic acid derivatives
ZA927500B (en) Substituted imidazolyl-propenoic acid derivatives.
ZA927499B (en) Cyclic-substituted imidazolyl-propenoic acid derivatives.
ZA927501B (en) Imidazolyl-propenoic acid derivatives.
HU9403116D0 (en) Epoxy-succinic acid derivatives
ZA929330B (en) Thiazolyl-substituted quinolylmethoxyphenylacetic acid derivatives.
EP0593464A4 (en) BENZOIC ACID DERIVATIVES.
OA09716A (en) Benzoxaiole derivatives.
HU9400745D0 (en) 2,4-diamino-3-hydroxy-carboxylic acid derivatives
ZA941668B (en) Acyloxyhexanoic acid derivatives
HU9302728D0 (en) Pyridazinone-acetic acid derivatives
ZA928275B (en) Quinoxaline-carboxylic and -phosphonic acid derivatives.
IL110170A0 (en) 2-Oximino-2-thienyl-acetic acid derivatives
ZA941923B (en) Phenoxyphenylacetic acid derivatives
ZA928736B (en) Amino acid derivatives.
ZA93737B (en) Aminobenzoic acid derivatives.
ZA922831B (en) Novel thienyl-nonatetraenoic acid derivatives
ZA928768B (en) Acetic acid derivatives.
ZA922022B (en) N-acyl-alpha-amino acid derivatives